Skip to main content
. Author manuscript; available in PMC: 2021 Jan 5.
Published in final edited form as: Int J Pharm. 2019 Nov 23;573:118894. doi: 10.1016/j.ijpharm.2019.118894

Table 1.

Physicochemical characteristics of the prepared Chi/siRNA complexes.

C/N/P (molar ratio) Ave DH (nm) Ave PDI Ave ξ (mV) siRNA loading efficiency (%)
0/20/1 195.6 ± 2.55 0.38 ± 0.023 13.3 ± 2.00 83.53 ± 1.85
10/20/1 165.8 ± 2.80*** 0.24 ± 0.011 −18.0 ± 0.40 81.81 ± 1.70
20/20/1 169.3 ± 4.42*** 0.29 ± 0.033 −20.5 ± 0.99 83.34 ± 1.29
40/20/1 169.4 ± 5.39** 0.19 ± 0.015 −21.7 ± 3.43 83.50 ± 1.37
0/40/1 174.3 ± 7.72 0.26 ± 0.013 13.9 ± 1.44 89.15 ± 1.35
10/40/1 186.4 ± 5.66 0.19 ± 0.015 −16.4 ± 0.15 91.75 ± 0.95
20/40/1 184.6 ± 13.1 0.28 ± 0.015 −18.8 ± 0.21 90.02 ± 1.15
40/40/1 189.6 ± 3.71 0.16 ± 0.011 −24.3 ± 1.06 88.98 ± 1.24
DF-siRNA 192.0 ± 7.42 0.31 ± 0.042 48.6 ± 3.53 89.69 ± 1.06

Statistical analysis comparing HA coated Chi/siRNA complexes to the non-coated Chi/siRNA complexes.

**

p<0.01;

***

p<0.001.